Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression

被引:87
作者
Connolly, Diana [1 ]
Yang, Zhixia [1 ]
Castaldi, Maria [2 ]
Simmons, Nichelle [3 ]
Oktay, Maja H. [4 ]
Coniglio, Salvatore [5 ]
Fazzari, Melissa J. [6 ]
Verdier-Pinard, Pascal [7 ,8 ,9 ]
Montagna, Cristina [1 ,4 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA
[2] Jacobi Med Ctr, Dept Surg, Bronx, NY 10461 USA
[3] Jacobi Med Ctr, Dept Pathol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[5] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA
[6] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA
[7] Ctr Rech Cancerol Marseille, INSERM, U891, F-13273 Marseille 09, France
[8] Inst J Paoli I Calmettes, F-13009 Marseille, France
[9] Aix Marseille Univ, F-13007 Marseille, France
来源
BREAST CANCER RESEARCH | 2011年 / 13卷 / 04期
关键词
Septin; 9; breast cancer; oncogene; epigenetics; cytoskeleton; HIGH SEPT9-V1 EXPRESSION; SQUAMOUS-CELL CARCINOMA; ACUTE MYELOID-LEUKEMIA; COLORECTAL-CANCER; MAMMALIAN SEPTIN; DNA METHYLATION; MASS-SPECTROMETRY; GENE FAMILY; MSF-A; LINES;
D O I
10.1186/bcr2924
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Altered expression of Septin 9 (SEPT9), a septin coding for multiple isoform variants, has been observed in several carcinomas, including colorectal, head and neck, ovarian and breast, compared to normal tissues. The mechanisms regulating its expression during tumor initiation and progression in vivo and the oncogenic function of its different isoforms remain elusive. Methods: Using an integrative approach, we investigated SEPT9 at the genetic, epigenetic, mRNA and protein levels in breast cancer. We analyzed a panel of breast cancer cell lines, human primary tumors and corresponding tumor-free areas, normal breast tissues from reduction mammoplasty patients, as well as primary mammary gland adenocarcinomas derived from the polyoma virus middle T antigen, or PyMT, mouse model. MCF7 clones expressing individual GFP-tagged SEPT9 isoforms were used to determine their respective intracellular distributions and effects on cell migration. Results: An overall increase in gene amplification and altered expression of SEPT9 were observed during breast tumorigenesis. We identified an intragenic alternative promoter at which methylation regulates SEPT9_v3 expression. Transfection of specific GFP-SEPT9 isoforms in MCF7 cells indicates that these isoforms exhibit differential localization and affect migration rates. Additionally, the loss of an uncharacterized SEPT9 nucleolar localization is observed during tumorigenesis. Conclusions: In this study, we found conserved in vivo changes of SEPT9 gene amplification and overexpression during human and mouse breast tumorigenesis. We show that DNA methylation is a prominent mechanism responsible for regulating differential SEPT9 isoform expression and that breast tumor samples exhibit distinctive SEPT9 intracellular localization. Together, these findings support the significance of SEPT9 as a promising tool in breast cancer detection and further emphasize the importance of analyzing and targeting SEPT9 isoform-specific expression and function.
引用
收藏
页数:16
相关论文
共 51 条
[1]   MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis [J].
Amir, S ;
Wang, RX ;
Matzkin, H ;
Simons, JW ;
Mabjeesh, NJ .
CANCER RESEARCH, 2006, 66 (02) :856-866
[2]   Targeted Knockdown of SEPT9_ v1 Inhibits Tumor Growth and Angiogenesis of Human Prostate Cancer Cells Concomitant with Disruption of Hypoxia-Inducible Factor-1 Pathway [J].
Amir, Sharon ;
Golan, Maya ;
Mabjeesh, Nicola J. .
MOLECULAR CANCER RESEARCH, 2010, 8 (05) :643-652
[3]  
[Anonymous], IMAGEJ SOFTWARE
[4]  
BATES D, 2008, R LANGUAGE ENV STAT
[5]   Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma [J].
Bennett, Kristi L. ;
Karpenko, Matthew ;
Lin, Mau-ting ;
Claus, Rainer ;
Arab, Khelifa ;
Dyckhoff, Gerhard ;
Plinkert, Peter ;
Herpel, Esther ;
Smiraglia, Dominic ;
Plass, Christoph .
CANCER RESEARCH, 2008, 68 (12) :4494-4499
[6]   Breast cancer cell lines: friend or foe? [J].
Burdall, SE ;
Hanby, AM ;
Lansdown, MRJ ;
Speirs, V .
BREAST CANCER RESEARCH, 2003, 5 (02) :89-95
[7]   Altered expression of the septin gene, SEPT9, in ovarian neoplasia [J].
Burrows, JF ;
Chanduloy, S ;
McIlhatton, MA ;
Nagar, H ;
Yeates, K ;
Donaghy, P ;
Price, J ;
Godwin, AK ;
Johnston, PG ;
Russell, SHE .
JOURNAL OF PATHOLOGY, 2003, 201 (04) :581-588
[8]   Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer [J].
deVos, Theo ;
Tetzner, Reimo ;
Model, Fabian ;
Weiss, Gunter ;
Schuster, Matthias ;
Distler, Juergen ;
Steiger, Kathryn V. ;
Gruetzmann, Robert ;
Pilarsky, Christian ;
Habermann, Jens K. ;
Fleshner, Phillip R. ;
Oubre, Benton M. ;
Day, Robert ;
Sledziewski, Andrew Z. ;
Lofton-Day, Catherine .
CLINICAL CHEMISTRY, 2009, 55 (07) :1337-1346
[9]   Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer [J].
Downing, Tricia E. ;
Oktay, Maja H. ;
Fazzari, Melissa J. ;
Montagna, Cristina .
CANCER GENETICS AND CYTOGENETICS, 2010, 198 (01) :52-61
[10]   Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry [J].
Ehrich, M ;
Nelson, MR ;
Stanssens, P ;
Zabeau, M ;
Liloglou, T ;
Xinarianos, G ;
Cantor, CR ;
Field, JK ;
van den Boom, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) :15785-15790